Infliximab Clinical Trials
18 recruitingDrug
Phase 46Phase 25Phase 33Phase 12Not Applicable2
Showing 1–18 of 18 trials
Recruiting
Not Applicable
Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission
Takayasu Arteritis
Marmara University40 enrolled1 locationNCT07491913
Recruiting
Phase 4
Combined Immunosuppression for Pediatric Crohn's Disease
Crohn DiseaseImmunosuppressionChildren, Only+1 more
Children's Hospital of Fudan University128 enrolled1 locationNCT05043870
Recruiting
Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+41 more
M.D. Anderson Cancer Center800 enrolled1 locationNCT03819296
Recruiting
Phase 2
An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis
Relapsing Polychondritis
University of Pennsylvania20 enrolled1 locationNCT06941376
Recruiting
Phase 3
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Rheumatoid Arthritis
University of Nebraska400 enrolled1 locationNCT03414502
Recruiting
Phase 1Phase 2
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
StrokeVasculitisAneurysm+1 more
University of California, San Francisco8 enrolled1 locationNCT02638701
Recruiting
Phase 4
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Crohn Disease
Taizhou Mabtech Pharmaceutical Co.,Ltd30 enrolled1 locationNCT05906576
Recruiting
Phase 2
Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
Inflammatory Bowel DiseasesUlcerative Colitis
Medical University of Lodz172 enrolled1 locationNCT06453317
Recruiting
Phase 2
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
InflammationDepressive Disorder, Major
Massachusetts General Hospital100 enrolled1 locationNCT06136546
Recruiting
Not Applicable
PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease
Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)
Pontificia Universidad Catolica de Chile72 enrolled1 locationNCT06758024
Recruiting
Phase 2Phase 3
Precise Infliximab Exposure and Pharmacodynamic Control
Crohn Disease
Children's Hospital Medical Center, Cincinnati180 enrolled11 locationsNCT05660746
Recruiting
Swiss Dermatology Network of Targeted Therapies (SDNTT)
Psoriasis
Swiss Dermatology Network for Targeted Therapies1,121 enrolled6 locationsNCT01706692
Recruiting
Phase 4
Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease
Crohn DiseaseChild, OnlyBiologic; Inadequate
Erasmus Medical Center50 enrolled1 locationNCT05552287
Recruiting
CHronic Nonbacterial Osteomyelitis International Registry
Chronic Recurrent Multifocal OsteomyelitisChronic Nonbacterial Osteomyelitis
Seattle Children's Hospital2,000 enrolled1 locationNCT04725422
Recruiting
Phase 4
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW275 enrolled15 locationsNCT06113913
Recruiting
Phase 4
Anti-Inflammatory Challenge in Schizophrenia
Schizophrenia
Emory University20 enrolled2 locationsNCT05823532
Recruiting
Phase 4
Top Down Versus Step up in Pediatric Ulcerative Colitis
Ulcerative ColitisChildrenInfliximab
Children's Hospital of Fudan University40 enrolled1 locationNCT04999228
Recruiting
Phase 3
Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
Colitis
Odense University Hospital195 enrolled3 locationsNCT05947669